Samia El BaroudyPartner at RMBVSpeaker
Profile
Samia ElBaroudy has a career spanning nearly 20 years in private equity and management consulting, leading investments from origination through value creation to exit across a broad range of industries. She is a Partner at RMBV, which invests in mid-market companies in Egypt, Morocco and Tunisia across the consumer, healthcare, education and financial services sectors. She currently sits on the board and serves on the audit committee of Cleopatra Hospitals Group, Egypt’s largest network of hospitals. In this role, she drove the platform’s expansion through M&A and the rollout of operational efficiencies. She is also a board member of Taaleem, the country’s largest higher education provider. Additionally, Samia chairs the audit committee of Macro Pharmaceuticals, a leading Egyptian cosmeceuticals company, where she is also a director. Previously, Samia worked with the leadership of Integrated Diagnostics Holdings (IDH), supporting its transition to a publicly listed company in London, the first Egyptian business to list on the London Stock Exchange. In 2026, she led RMBV’s participation, alongside IDH’s founder, in the mandatory tender offer for the company, returning to a business she helped bring to the public markets. Samia holds a bachelor’s degree in Economics and a master’s degree in Management Science and Engineering, both from Stanford University.
Agenda Sessions
Egypt: gateway to growth
, 14:10View Session
